Trial Profile
Effect of primary androgen deprivation therapy (ADT) on subsequent responses to androgen-receptor (AR)-targeting therapies
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Aug 2015
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 19 Aug 2015 New trial record